Publication & Citation Trends
Publications
0 total
Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT
Cited by 0
Semantic Scholar
Neoadjuvante Therapie – Chancen der Therapieoptimierung
Cited by 0
Semantic Scholar
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
Cited by 6
Semantic Scholar
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Cited by 0
Semantic Scholar
Patient outcomes in WSG-ADAPT according to NATALEE and MonarchE risk criteria.
Cited by 0
Semantic Scholar
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
Cited by 1
Semantic Scholar
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders
Cited by 3
Semantic Scholar
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer OA
Cited by 5
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(42)
Advanced Breast Cancer Therapies
(22)
HER2/EGFR in Cancer Research
(19)
BRCA gene mutations in cancer
(16)
Molecular Biology Techniques and Applications
(12)
Affiliations
University Medical Center Groningen
Institute of Cancer Research
Radboud University Nijmegen
Witten/Herdecke University
Universität Hamburg